The Active Surveillance Study
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorInstitute of Cancer Research, United Kingdom
About this trial
The Active Surveillance study is a prospective study developed to look at the association of biomarkers with PrCa presentation and progression among men on Active Surveillance and stratify it by their genetic risk. This study will also investigate the incidence and progression by differing genetic risks.
Eligibility criteria
Qualifiers
Men ≥18 years old under the care of an Active Surveillance clinic.
Known diagnosis of PrCa, deemed suitable for Active surveillance at multi-disciplinary meeting (MDT).
Having a first degree relative (or second degree if through female line) with histologically or death certificate proven PrCa diagnosed at <70 years
Having two relatives on the same side of the family with histologically or death certificate proven PrCa where at least one is diagnosed at <70 years
Disqualifiers
No PrCa diagnosis
PrCa diagnosis that is not deemed suitable for active surveillance at multi-disciplinary meeting
Any significant psychological conditions that may be worsened or exacerbated by participation in the study
Trial design
Treatments tested in this trial
- Active Surveillance
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Institute of Cancer Research, United Kingdom
Lead sponsor
Royal Marsden NHS Foundation Trust
Collaborator
North Bristol NHS Trust
Collaborator
Source ClinicalTrials.gov